STOCK TITAN

INTERVENT International and Brand Engagement Network Launch INTERVENT Health AI, Inc., Combining 25+ Years of Clinically Validated Health Coaching with Enterprise-Grade Conversational AI

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Positive)
Tags
AI

Brand Engagement Network (NASDAQ:BNAI) and INTERVENT International launched INTERVENT Health AI, a 50/50 joint venture to commercialize AI-powered health coaching and chronic disease management solutions.

The venture combines BEN's enterprise conversational AI with INTERVENT's 25+ years of clinically validated telehealth coaching and outcomes data to target global employer, payer, and healthcare markets.

Loading...
Loading translation...

AI-generated analysis. Not financial advice.

Positive

  • 50/50 joint venture creates new AI health coaching platform
  • BEN named exclusive AI software provider for North America for five years
  • BEN to earn revenue from software licensing, deployment, and commercialization services
  • Long-term licensing of BEN's conversational AI and enterprise AI systems
  • INTERVENT contributes 25+ years of clinically validated coaching methodologies and datasets
  • Programs supported by 120+ scientific publications and 2M+ individuals served

Negative

  • None.

Key Figures

Individuals served: more than 2 million Medical centers: 150+ Clinical experience: more than 25 years +3 more
6 metrics
Individuals served more than 2 million INTERVENT health coaching programs to date
Medical centers 150+ Sites where INTERVENT programs have been studied or used
Clinical experience more than 25 years Clinically validated telehealth coaching experience base
Published studies more than 120 Scientific abstracts and manuscripts supporting INTERVENT programs
Joint venture ownership 50/50 Ownership split in INTERVENT Health AI, Inc.
Exclusive AI term five-year term BEN as exclusive AI software provider for North American operations

Market Reality Check

Price: $20.62 Vol: Volume 381,448 is below 2...
low vol
$20.62 Last Close
Volume Volume 381,448 is below 20-day average 878,541 (relative volume 0.43x). low
Technical Trading above 200-day MA, with price 20.62 vs 200-day MA 16.75.

Peers on Argus

BNAI is up 4.74% while momentum peers DTSS, TAOP, and MSAI show median moves aro...
3 Down

BNAI is up 4.74% while momentum peers DTSS, TAOP, and MSAI show median moves around -4.1%, indicating this AI healthcare JV headline is more stock-specific than sector-driven.

Previous AI Reports

5 past events · Latest: Mar 02 (Positive)
Same Type Pattern 5 events
Date Event Sentiment Move Catalyst
Mar 02 AI deployment update Positive +2.8% Live guest-facing deployment of AI Concierge at a resort property.
Dec 29 AI pharma contract Positive +108.8% AI engagement solution agreement for top-10 global pharmaceutical client.
Dec 11 AI healthcare JV Positive -3.7% Formation of Skye Salud to deploy sovereign AI for Mexican healthcare.
Sep 19 Board and AI agent Positive -3.2% New board member and debut of an insurance-focused AI Agent.
Jun 04 AI mental health Positive +3.8% Launch of AI mental health support program for underserved students.
Pattern Detected

AI-related announcements have often produced positive but variable one-day moves, including one triple-digit gain but also some negative reactions.

Recent Company History

Over the past year, BEN’s AI-tagged news has focused on deploying its conversational AI into real-world settings. Events include a live AI Concierge rollout on Mar 02, 2026, a pharma-focused AI engagement deal on Dec 29, 2025, and formation of the Skye Salud sovereign healthcare platform on Dec 11, 2025. Additional AI agent and mental health initiatives broadened use cases. Today’s INTERVENT Health AI venture extends this pattern of embedding BEN’s AI into healthcare workflows and partnerships.

Historical Comparison

+21.7% avg move · In the past year, BEN released 5 AI-tagged updates with an average one-day move of 21.69%. Today’s A...
AI
+21.7%
Average Historical Move AI

In the past year, BEN released 5 AI-tagged updates with an average one-day move of 21.69%. Today’s AI healthcare JV fits the pattern of healthcare-focused AI deployments but with a more moderate immediate impact.

AI initiatives have progressed from pilots and regional healthcare programs toward broader, multi-continent healthcare platforms and now an evidence-based chronic disease coaching JV.

Market Pulse Summary

The stock is up +5.1% following this news. A strong positive reaction aligns with BEN’s history of o...
Analysis

The stock is up +5.1% following this news. A strong positive reaction aligns with BEN’s history of outsized moves on AI-related announcements, where prior AI-tagged news averaged 21.69% one-day swings. However, past patterns also included negative follow-through on some positive updates, underscoring execution and integration risks. Investors watching this JV may focus on concrete commercialization metrics such as contract wins, deployment scale, and demonstrated health outcomes to assess durability of enthusiasm.

Key Terms

telehealth, conversational AI, hipaa-compliant, population health, +1 more
5 terms
telehealth medical
"built on more than 25 years of clinically validated telehealth coaching experience"
Telehealth is the delivery of healthcare services and consultations remotely using video calls, phone, text messaging, or connected devices to monitor and transmit medical information. It matters to investors because it can reshape how patients access care, lower costs, and create new revenue streams or risks for healthcare providers, insurers and technology companies—similar to how online banking changed financial services—while also exposing businesses to reimbursement and regulatory shifts.
conversational AI technical
"BEN's conversational AI is expected to help scale these evidence-based coaching systems"
Conversational AI is technology that allows computers to understand, process, and respond to human language in a way that feels natural and interactive, similar to chatting with a person. It enables machines to hold conversations, answer questions, and assist with tasks automatically. For investors, it matters because this technology can improve customer service, streamline operations, and create new opportunities across many industries.
hipaa-compliant regulatory
"supported by a research-grade, HIPAA-compliant database of millions of deidentified"
HIPAA-compliant means that a product, service, or organization follows the U.S. Health Insurance Portability and Accountability Act’s rules for protecting patients’ private health information, including technical controls, physical safeguards, and record-keeping. For investors, compliance matters because it reduces risks of costly fines, lawsuits and reputational damage, and it can be a requirement to sell into healthcare markets — like having a certified lockbox and an audit trail that reassures customers and regulators.
population health medical
"provider of evidence-based health coaching and population health solutions"
Population health is the practice of improving the overall health and well‑being of a group of people — such as residents of a region or users of a health plan — by preventing illness, managing chronic conditions, and coordinating services. Think of it like maintaining a city's infrastructure: healthier populations need fewer emergency repairs and lower long‑term costs. For investors, stronger population health can reduce healthcare spending, stabilize revenue for providers and insurers, and lower financial risk tied to disease outbreaks or rising chronic care needs.
remote patient monitoring medical
"pharmaceutical companies, remote patient monitoring providers, wellness organizations"
Remote patient monitoring is the ongoing collection and transmission of a person’s health data (such as heart rate, blood sugar, or blood pressure) from home or another non-clinical setting to healthcare providers using connected devices and secure networks. For investors, it matters because it can reduce hospital visits, create steady service and device revenue, and change how care is paid for—think of it as a home security system for health that can lower costs and improve outcomes.

AI-generated analysis. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

The joint venture combines BEN's enterprise conversational AI with INTERVENT's clinically validated health coaching programs, which have been used to serve more than 2 million individuals, including through 150+ medical centers and Fortune 100 employers.  

WILMINGTON, Del. and SAVANNAH, Ga., June 11, 2026 /PRNewswire/ -- Brand Engagement Network Inc. (NASDAQ: BNAI) ("BEN" or the "Company"), a provider of secure, enterprise-grade artificial intelligence for the engagement layer of AI, and INTERVENT International ("INTERVENT"), a physician-led provider of evidence-based health coaching and population health solutions, today announced the launch of INTERVENT Health AI, Inc., a jointly owned venture designed to commercialize AI-powered health coaching and chronic disease management solutions built on more than 25 years of clinically validated telehealth coaching experience. 

INTERVENT International and Brand Engagement Network Launch INTERVENT Health AI, Inc., Combining 25+ Years of Clinically Validated Health Coaching with Enterprise-Grade Conversational AI

While many AI healthcare applications rely primarily on publicly available information to answer questions, INTERVENT Health AI is being built on more than 25 years of clinically validated health coaching methodologies designed to drive measurable behavior change and favorable long-term health outcomes. According to information provided by INTERVENT, its programs have been used to serve more than two million individuals and are supported by more than 120 published scientific abstracts and manuscripts, including studies conducted across more than 150 medical centers with funding from organizations such as the NIH, PCORI, and the Public Health Agency of Canada. Through INTERVENT Health AI, BEN's conversational AI is expected to help scale these evidence-based coaching systems to broader populations and new healthcare markets. 

INTERVENT Health AI, Inc., is structured as a 50/50 joint venture. INTERVENT contributes its clinically validated coaching methodologies, proprietary care pathways, behavior change content, and healthcare datasets, while BEN contributes its conversational AI, enterprise AI systems, and related intellectual property, each through long-term licensing and services arrangements. BEN is expected to generate revenue through software licensing, deployment, and commercialization services and to serve as the exclusive AI software provider for North American operations for an initial five-year term, subject to agreed performance milestones. 

"We believe the next generation of healthcare AI will be built on trusted clinical methodologies, real-world outcomes data, and scalable AI infrastructure," said Tyler Luck, Chief Executive Officer of BEN. "INTERVENT has spent more than two decades developing and validating coaching systems designed to improve health outcomes. BEN's role is to help transform those proven systems into AI-powered solutions that can be deployed more broadly, more efficiently, and across a wider range of healthcare and commercial settings." 
 
INTERVENT's programs have demonstrated impressive outcomes across employer, payer, and healthcare system markets, including improvements in cardiovascular risk factors, health behaviors, and chronic disease-related markers. Published studies have linked INTERVENT's programs to reductions in major adverse cardiovascular events and favorable return-on-investment outcomes for employers, as well as clinically meaningful improvements in measures associated with prediabetes and type 2 diabetes. According to information provided by INTERVENT, these outcomes are supported by a research-grade, HIPAA-compliant database of millions of deidentified structured health record data points and hundreds of thousands of telehealth coaching interactions, linked to longitudinal patient outcomes. 

"For decades, INTERVENT has focused on developing, testing, and implementing evidence-based coaching systems designed to achieve favorable long-term health outcomes," said Dr. Neil Gordon, Chief Executive Officer of INTERVENT and newly appointed Chairman of INTERVENT Health AI. "By combining that foundation with BEN's conversational AI technologies, we believe INTERVENT Health AI can help expand access to even more innovative, scalable, and cost-effective behaviorally oriented healthcare support in an unprecedented manner."  
 
INTERVENT Health AI will serve employers, insurers, healthcare systems, pharmaceutical companies, remote patient monitoring providers, wellness organizations, and other healthcare stakeholders across North America, Latin America, Africa, and certain other geographies, building on existing relationships maintained by both INTERVENT and BEN. BEN expects to generate revenue through its ownership interest in the venture, as well as through software licensing, deployment, and ongoing commercialization services, while retaining ownership of its core artificial intelligence technologies and related intellectual property. 

About Brand Engagement Network, Inc.   
Brand Engagement Network, Inc. ("BEN") builds secure, enterprise-grade artificial intelligence for the engagement layer of AI, where people interact with systems and actions occur. Powered by BEN's proprietary Engagement Language Model (ELM™), BEN's technology enables conversational AI interactions that connect human intent to organizational data, workflows, and real-world outcomes. BEN's AI operates within secure closed-loop environments using approved organizational data and built-in governance and compliance controls. Trusted by organizations operating in regulated and high-impact industries, BEN helps bring AI into real operational settings where engagement drives outcomes and accountability matters.   
For more information, visit Brand Engagement Network.  

About INTERVENT International  
INTERVENT International is a physician-led, global provider of digital health coaching and population health management solutions. Founded in 1997, INTERVENT develops and delivers evidence-based, technology-enabled programs designed to support the prevention and management of chronic disease across diverse populations. According to information provided by INTERVENT, its programs have served more than 2 million individuals globally and have been validated by more than 120 published scientific abstracts and manuscripts, including independent third-party research.   
For more information, visit INTERVENT International.  

Media Contact:  
amy@beninc.ai  

Investor Relations:  
investors@beninc.ai  

Forward-Looking Statements  
This press release contains forward-looking statements within the meaning of the federal securities laws. These forward-looking statements include, but are not limited to, statements regarding the expected benefits of the agreement with INTERVENT, the development and commercialization of AI-driven health coaching solutions, anticipated licensing and revenue opportunities, future enterprise deployments, commercialization activities, anticipated applications of BEN's technologies, expected market demand, and the capabilities or performance of AI-enabled healthcare engagement systems. These statements are based on current expectations, estimates, and assumptions and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Factors that may cause such differences include, but are not limited to, successful execution of the initiative, customer adoption, product development timelines, regulatory and healthcare compliance considerations, commercialization outcomes, financing conditions, intellectual property protection, and general economic and market conditions. BEN undertakes no obligation to update any forward-looking statements, except as required by law.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/intervent-international-and-brand-engagement-network-launch-intervent-health-ai-inc-combining-25-years-of-clinically-validated-health-coaching-with-enterprise-grade-conversational-ai-302797897.html

SOURCE Brand Engagement Network, Inc. (BEN)

FAQ

What did Brand Engagement Network (NASDAQ:BNAI) announce on June 11, 2026 about INTERVENT Health AI?

Brand Engagement Network announced a 50/50 joint venture with INTERVENT International called INTERVENT Health AI. According to BEN, the venture will commercialize AI-powered health coaching and chronic disease management solutions using INTERVENT’s validated methodologies and BEN’s enterprise conversational AI technology.

How is the INTERVENT Health AI joint venture between BNAI and INTERVENT structured?

INTERVENT Health AI is structured as a 50/50 joint venture between BEN and INTERVENT. According to BEN, INTERVENT licenses its coaching methodologies and datasets, while BEN licenses conversational AI and enterprise systems under long-term agreements and provides commercialization services.

How will Brand Engagement Network (BNAI) generate revenue from INTERVENT Health AI?

Brand Engagement Network expects to generate revenue through its ownership interest and through software licensing, deployment, and commercialization services. According to BEN, it will also serve as exclusive AI software provider for North American operations for an initial five-year term, subject to milestones.

What clinical foundation supports the INTERVENT Health AI platform launched by BNAI and INTERVENT?

The platform is built on more than 25 years of clinically validated health coaching methodologies. According to INTERVENT, programs have served over two million individuals and are supported by 120+ scientific abstracts and manuscripts across 150+ medical centers with major research funding.

Which markets will INTERVENT Health AI target following the BNAI joint venture launch?

INTERVENT Health AI plans to serve employers, insurers, healthcare systems, pharmaceutical companies, and wellness organizations. According to BEN, the venture will operate across North America, Latin America, Africa, and selected other geographies, leveraging existing relationships from both partners.

What role does Brand Engagement Network's conversational AI play in INTERVENT Health AI?

Brand Engagement Network’s conversational AI will power scalable, evidence-based digital coaching. According to BEN, its systems are expected to extend INTERVENT’s proven telehealth coaching to broader populations and new healthcare markets while BEN retains ownership of its core AI technologies and intellectual property.